The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

Title:The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

Volume: 14 Issue: 1

Author(s): Alicia M. Waters and Elizabeth A. Beierle

Affiliation:

Keywords: FAK, Mdm2, MYCN, neuroblastoma, p53.

Abstract: Neuroblastoma tumorigenesis and malignant transformation is driven by overexpression and dominance of cell survival pathways and a lack of normal cellular senescence or apoptosis. Therefore, manipulation of cell survival pathways may decrease the malignant potential of these tumors and provide avenues for the development of novel therapeutics. This review focuses on the individual protein tyrosine kinase, focal adhesion kinase (FAK) and its interaction with the transcription factors, MYCN, p53, and Mdm2, and how their interactions modulate the growth and malignancy of neuroblastomas.

Cite this article as:

Waters M. Alicia and Beierle A. Elizabeth, The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma, Anti-Cancer Agents in Medicinal Chemistry 2014; 14 (1) . https://dx.doi.org/10.2174/18715206113136660331